Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biosplice Therapeutics

Request full access

Medical research and development for tissue-level regeneration

San Diego, United StatesFounded 2008Biotech & Life Sciences
Valuation $10–50B Last recorded · 2026
Headcount <100 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Biosplice Therapeutics and the history behind them.

At a glance

Founded
2008
Headquarters
San Diego, United States
Sector
Biotech & Life Sciences
Outcome tier
Decacorn$10B+ valuation tier

Knowledge graph

Founder mafias, market maps, lists and research connected to this company by Dealroom
Market map
Market map billionaire funded longevity startups
Unicorn lists
Biotech & Life Sciences unicorns Unicorn list Biotech & Life Sciences unicorns Unicorns in United States Unicorn list Unicorns in United States

Open roles

Track hiring at Biosplice TherapeuticsOpen roles, team growth and hiring by functionBook a demo
Looking for a job? The startup jobs board lists open roles.Startups hiring now →

Biosplice Therapeutics in the San Diego ecosystem

Live from Dealroom

The Biosplice Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Esas Ventures

Series A3 investors entered at this stage

  • Starling group
  • Polar Light Ventures
  • Vickers Venture Partners

Series B and later6 investors entered at this stage

  • Christian Cadeo
  • Symbiosis Group
  • Eventide Asset Management
  • Cem Ortabaş
  • aMoon Fund
  • Verition Fund Management

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

40% Founders
  • 13%
  • 9%
  • 5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States91%
🇹🇷 Turkey9%
2 countries shown
Web traffic by country
2.1K monthly visits
across markets
🇺🇸 United States95.2%
🇮🇳 India9.5%
Top 2 markets shown

Patents

Estimated portfolio value
$170M

70 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Biosplice Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biosplice Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles